Alvotech(ALVO) - 2024 Q4 - Annual Report

EXHIBIT 99.1 Alvotech Reports Record Results for 2024 and Provides Business Update REYKJAVIK, Iceland, March 26, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the "Company"), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for full year 2024 and provided a summary of recent pipeline and corporate highlights. Management will conduct a business update conference call and live webcast on March 27, 20 ...